346900789	346900789	CD	B-NP	O
|	|	NN	I-NP	O
NMC	NMC	NN	I-NP	O
|	|	NN	I-NP	O
23097152	23097152	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
107945	107945	CD	B-NP	O
|	|	CC	I-NP	O
4/16/1999	4/16/1999	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
PYELONEPHRITIS	PYELONEPHRITIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/16/1999	4/16/1999	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/10/1999	1/10/1999	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
HYPEROSMOLAR	HYPEROSMOLAR	NN	B-NP	O
STATE	STATE	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Rule	Rule	NN	B-NP	O
in	in	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Sal	Sal	NNP	B-NP	O
Sult	Sult	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
65	65	CD	I-NP	O
year-old	year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infections	infection	NNS	I-NP	O
who	who	WP	B-NP	O
noted	note	VBD	B-VP	O
cloudy	cloudy	NN	B-NP	O
urine	urine	NN	I-NP	O
five	five	CD	B-NP	O
days	day	NNS	I-NP	O
previous	previous	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
frequency	frequency	NN	I-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
clinic	clinic	NN	B-NP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
5th	5th	JJ	I-NP	B-cell_line
colonies	colony	NNS	I-NP	I-cell_line
of	of	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_line
urine	urine	NN	I-NP	I-cell_line
culture	culture	NN	I-NP	I-cell_line
.	.	.	O	O

Since	Since	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
developed	develop	VBD	B-VP	O
left	leave	VBN	I-VP	O
back	back	RP	B-PRT	O
pain	pain	NN	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	O
to	to	TO	B-PP	O
100.0	100.0	CD	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
vomiting	vomit	VBG	B-VP	O
x24	x24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
medical	medical	JJ	I-NP	O
doctor	doctor	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
temperature	temperature	NN	I-NP	O
of	of	IN	B-PP	O
98.2	98.2	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
128/54	128/54	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
to	to	TO	B-PP	O
112	112	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
finger	finger	NN	B-NP	O
stick	stick	NN	I-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
521	521	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
anion	anion	NN	I-NP	O
gap	gap	NN	I-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
15	15	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
was	be	VBD	B-VP	O
128	128	CD	B-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	B-protein
was	be	VBD	B-VP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
one	one	CD	B-NP	O
gram	gram	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
ceftriaxone	ceftriaxone	NN	I-NP	O
and	and	CC	O	O
5	5	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
x2	x2	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
syncope	syncope	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
denied	deny	VBD	B-VP	O
previous	previous	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infections	infection	NNS	I-NP	O
previously	previously	RB	B-VP	O
including	include	VBG	I-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
pyelonephritis	pyelonephritis	NN	B-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
7	7	CD	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
kidney	kidney	NN	B-NP	O
stones	stone	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
does	do	VBZ	B-VP	O
take	take	VB	I-VP	O
high	high	JJ	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
vitamin	vitamin	NN	B-NP	O
C.	C.	NNP	I-NP	O
Risk	Risk	NNP	I-NP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
included	include	VBD	B-VP	O
age	age	NN	B-NP	O
,	,	,	O	O
family	family	NN	B-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
postmenopausal	postmenopausal	JJ	B-NP	O
state	state	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
question	question	NN	B-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
medically	medically	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
recent	recent	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
palpitations	palpitation	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
last	last	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
reputedly	reputedly	RB	B-ADVP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
previously	previously	RB	B-ADVP	O
,	,	,	O	O
associated	associate	VBN	B-VP	O
with	with	IN	B-PP	O
stress	stress	NN	B-NP	O
of	of	IN	B-PP	O
work	work	NN	B-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
took	take	VBD	B-VP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
exertion	exertion	NN	B-NP	O
related	related	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
admit	admit	VB	I-VP	O
to	to	TO	B-PP	O
calf	calf	NN	B-NP	O
and	and	CC	O	O
``	``	``	B-NP	O
hip	hip	NN	I-NP	O
''	''	''	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
walking	walk	VBG	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
buttock	buttock	NN	B-NP	O
pain	pain	NN	I-NP	O
while	while	IN	B-SBAR	O
walking	walk	VBG	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
previous	previous	JJ	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
ketoacidosis	ketoacidosis	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
x20	x20	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
always	always	RB	B-ADVP	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
renal	renal	JJ	I-NP	O
,	,	,	I-NP	O
neurologic	neurologic	JJ	I-NP	O
,	,	,	I-NP	O
or	or	CC	I-NP	O
ophthalmologic	ophthalmologic	JJ	I-NP	O
complications	complication	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
x20	x20	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
MI	MI	NN	B-NP	O
,	,	,	O	O
CVA	CVA	NN	B-NP	B-protein
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
4/18	4/18	CD	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
:	:	:	O	O
standard	standard	JJ	B-NP	O
Bruce	Bruce	NN	I-NP	O
with	with	IN	B-PP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
to	to	TO	B-PP	O
110	110	CD	B-NP	O
,	,	,	O	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
predicted	predict	VBD	B-VP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
150/70	150/70	CD	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
improved	improve	VBN	B-VP	O
with	with	IN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depression	depression	NN	I-NP	O
in	in	IN	B-PP	O
leads	lead	NNS	B-NP	O
V3-V5	V3-V5	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pancreatitis	Pancreatitis	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Asthma	Asthma	NN	B-NP	O
x3	x3	CD	B-NP	O
years	year	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hypercholesterolemia	Hypercholesterolemia	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
issue	issue	NN	I-NP	O
was	be	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
with	with	IN	B-PP	O
?	?	.	O	O

diet	diet	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Cholecystectomy	Cholecystectomy	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Appendectomy	Appendectomy	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Metoprolol	Metoprolol	NN	B-NP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
isosorbide	isosorbide	NN	B-NP	O
dinitrate	dinitrate	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
zestril	zestril	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Premarin	Premarin	NN	B-NP	O
0.625	0.625	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
NPH	NPH	NN	B-NP	B-protein
30	30	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.	q.	VBG	B-VP	O
AM	AM	NN	B-NP	O
;	;	:	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
q.	q.	VBG	B-VP	O
AM	AM	NN	B-NP	O
;	;	:	O	O
vitamin	vitamin	NN	B-NP	O
B12	B12	NN	I-NP	O
;	;	:	O	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
1	1	CD	I-NP	O
gram	gram	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
;	;	:	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.o.	q.o.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Codeine	Codeine	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
causing	cause	VBG	B-VP	O
syncope	syncope	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
works	work	VBZ	B-VP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
nurse	nurse	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Nenteoaks	Nenteoaks	NNP	I-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
them	them	PRP	B-NP	O
with	with	IN	B-PP	O
psychiatric	psychiatric	JJ	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
divorced	divorce	VBN	I-VP	O
and	and	CC	O	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
smoking	smoking	NN	I-NP	O
,	,	,	O	O
rarely	rarely	RB	B-ADVP	O
drinks	drink	VBZ	B-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
three	three	CD	B-NP	O
cats	cat	NNS	I-NP	O
and	and	CC	O	O
one	one	CD	B-NP	O
dog	dog	NN	I-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
recent	recent	JJ	I-NP	O
travel	travel	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Father	Father	NN	B-NP	O
with	with	IN	B-PP	O
MI	MI	NN	B-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
55	55	CD	I-NP	O
;	;	:	O	O
he	he	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

Mother	Mother	DT	B-NP	O
with	with	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
82	82	CD	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	SYM	O	O
T	T	NN	B-NP	B-protein
max	max	NN	I-NP	I-protein
99.3	99.3	CD	I-NP	I-protein
,	,	,	O	O
pulse	pulse	NN	B-NP	O
104	104	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
131/60	131/60	CD	I-NP	O
,	,	,	O	O
respirations	respiration	NNS	B-NP	O
20	20	CD	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Moderately	Moderately	RB	B-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
lying	lie	VBG	B-VP	O
in	in	IN	B-PP	O
bed	bed	NN	B-NP	O
with	with	IN	B-PP	O
chills	chill	NNS	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
8	8	CD	B-NP	O
cm	cm	NN	I-NP	O
of	of	IN	B-PP	O
JVP	JVP	NN	B-NP	B-protein
.	.	.	O	O

Eyes	Eye	NNS	B-NP	O
PERRL	PERRL	NN	I-NP	B-protein
and	and	CC	I-NP	O
anicteric	anicteric	JJ	I-NP	O
,	,	,	I-NP	O
neck	neck	NN	I-NP	O
supple	supple	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
adenopathy	adenopathy	NN	I-NP	O
or	or	CC	I-NP	O
sinus	sinus	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
.	.	.	O	O

CHEST	CHEST	NN	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

2/6	2/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
gallops	gallop	NNS	I-NP	O
or	or	CC	I-NP	O
rubs	rub	NNS	I-NP	O
.	.	.	O	O

S1	S1	NN	B-NP	B-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
non-tender	non-tender	JJ	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
hepatomegaly	hepatomegaly	NN	I-NP	O
or	or	CC	I-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

BACK	BACK	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
costovertebral	costovertebral	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
pedal	pedal	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Dorsalis	Dorsalis	NNP	B-NP	O
pedis	pedis	NN	I-NP	O
equals	equal	VBZ	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
Oriented	Orient	VBN	B-VP	O
.	.	.	O	O

Cranial	Cranial	NNP	B-NP	O
nerves	nerve	VBZ	B-VP	O
2-12	2-12	CD	B-NP	O
intact	intact	JJ	I-NP	O
.	.	.	O	O

Strength	Strength	NN	B-NP	O
5/5	5/5	CD	I-NP	O
in	in	IN	B-PP	O
all	all	DT	B-NP	O
groups	group	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Urinalysis	Urinalysis	NN	B-NP	O
-	-	HYPH	B-NP	O
A	A	NN	I-NP	O
specific	specific	JJ	I-NP	O
gravity	gravity	NN	I-NP	O
of	of	IN	B-PP	O
1.025	1.025	CD	B-NP	O
/	/	SYM	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	I-NP	O
protein/3	protein/3	NN	I-NP	O
+	+	SYM	B-NP	O
glucose/trace	glucose/trace	NN	I-NP	B-protein
ketones/trace	ketones/trace	NN	I-NP	I-protein
blood/negative	blood/negative	JJ	I-NP	I-protein
leukocyte	leukocyte	NN	I-NP	I-protein
esterase/negative	esterase/negative	JJ	I-NP	I-protein
nitrates/3	nitrates/3	NN	I-NP	I-protein
-6	-6	CD	I-NP	I-protein
white	white	JJ	I-NP	I-protein
blood	blood	NN	I-NP	I-protein
cells/3	cells/3	NN	I-NP	I-protein
-6	-6	CD	I-NP	I-protein
red	red	JJ	I-NP	I-protein
blood	blood	NN	I-NP	I-protein
cells/1	cells/1	NN	I-NP	I-protein
+	+	CC	O	O
bacteria/negative	bacteria/negative	JJ	B-NP	O
casts/1	casts/1	NN	I-NP	O
+	+	SYM	B-NP	O
epis	epis	NN	I-NP	O
.	.	.	O	O

Sodium	Sodium	NN	B-NP	B-protein
135	135	CD	I-NP	I-protein
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
97	97	CD	I-NP	O
,	,	,	O	O
CO2	CO2	NN	B-NP	O
21	21	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
29	29	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.6	1.6	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
459	459	CD	I-NP	O
.	.	.	O	O

Acetest	Acetest	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
26.48	26.48	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
41.3	41.3	CD	I-NP	I-protein
,	,	,	O	O
MCV	MCV	NN	B-NP	B-protein
89.9	89.9	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
278	278	CD	B-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
differential	differential	JJ	B-ADJP	O
with	with	IN	B-PP	O
81	81	CD	B-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
13	13	CD	B-NP	O
bands	band	NNS	I-NP	O
,	,	,	O	O
4	4	CD	B-NP	O
lymphs	lymph	NNS	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
monos	mono	NNS	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
113	113	CD	B-NP	O
,	,	,	O	O
axis	axis	NN	B-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
negative	negative	JJ	B-ADJP	O
to	to	TO	B-PP	O
37	37	CD	B-NP	O
,	,	,	O	O
intervals	interval	NNS	B-NP	O
equal	equal	JJ	B-ADJP	O
to	to	TO	B-PP	O
152/90/450	152/90/450	CD	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
old	old	JJ	B-NP	O
Qs	Q	NNS	I-NP	O
in	in	IN	B-PP	O
V1	V1	NN	B-NP	O
and	and	CC	I-NP	O
V2	V2	NN	I-NP	B-protein
,	,	,	O	O
left	leave	VBD	B-VP	O
anterior	anterior	JJ	B-NP	O
hemiblock	hemiblock	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
ventricular	ventricular	JJ	B-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
cardiomegaly	cardiomegaly	RB	B-ADVP	O
,	,	,	O	O
or	or	CC	O	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
glucose	glucose	NN	I-NP	O
came	come	VBD	B-VP	O
down	down	RB	B-ADVP	O
quickly	quickly	RB	B-ADVP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
and	and	CC	O	O
aggressive	aggressive	JJ	B-NP	O
hydration	hydration	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
unfortunately	unfortunately	RB	B-ADVP	O
ruled	rule	VBD	B-VP	O
in	in	IN	B-PP	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
peak	peak	JJ	B-NP	O
CK	CK	NN	I-NP	O
on	on	IN	B-PP	O
4/13/99	4/13/99	CD	B-NP	O
of	of	IN	B-PP	O
285	285	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
peak	peak	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
6.15	6.15	CD	B-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
beta	beta	NN	B-NP	O
blockers	blocker	NNS	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
Zestril	Zestril	NNP	B-NP	O
and	and	CC	I-NP	O
Zocor	Zocor	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
recurrent	recurrent	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
following	follow	VBG	B-PP	O
her	her	PRP$	B-NP	O
non-Q	non-Q	JJ	I-NP	O
wave	wave	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
on	on	IN	B-PP	O
4/13/99	4/13/99	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
hypokinesis	hypokinesis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
middle	middle	JJ	I-NP	O
and	and	CC	I-NP	O
distal	distal	JJ	I-NP	O
intraventricular	intraventricular	JJ	I-NP	O
septum	septum	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	B-protein
had	have	VBD	B-VP	I-protein
1	1	CD	B-NP	I-protein
+	+	SYM	I-NP	O
tricuspid	tricuspid	NN	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
and	and	CC	O	O
preserved	preserve	VBN	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
1/12/99	1/12/99	CD	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
osteo	osteo	NN	I-NP	O
left	leave	VBD	B-VP	O
main	main	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
tapered	taper	VBD	B-VP	O
distal	distal	JJ	B-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
left	left	JJ	I-NP	O
anterior	anterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
was	be	VBD	B-VP	O
diffusely	diffusely	RB	I-VP	O
diseased	disease	VBN	I-VP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
50	50	CD	I-NP	O
%	%	NN	I-NP	O
in	in	IN	B-PP	O
its	its	PRP$	B-NP	O
mid	mid	JJ	I-NP	O
portion	portion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
diagonal	diagonal	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
70	70	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
second	second	JJ	I-NP	O
diagonal	diagonal	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
discrete	discrete	JJ	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
discrete	discrete	JJ	I-NP	O
proximal	proximal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
posterior	posterior	JJ	I-NP	O
descending	descend	VBG	I-NP	O
artery	artery	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
osteo	osteo	JJ	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
on	on	IN	B-PP	O
10/4/99	10/4/99	CD	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	O
Bruce	Bruce	NNP	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
9	9	CD	I-NP	O
minute	minute	NN	I-NP	O
test	test	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
of	of	IN	B-PP	O
predicted	predict	VBN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
maximum	maximum	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
156/60	156/60	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
interpreted	interpret	VBN	I-VP	O
as	as	IN	B-PP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
probably	probably	RB	I-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
CABG	CABG	NN	B-NP	O
procedure	procedure	NN	I-NP	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
deferred	defer	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
preference	preference	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
infectious	infectious	JJ	I-NP	O
disease	disease	NN	I-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
persistently	persistently	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
one	one	CD	B-NP	O
urine	urine	NN	I-NP	O
culture	culture	NN	I-NP	O
which	which	WDT	B-NP	O
appeared	appear	VBD	B-VP	O
contaminated	contaminate	VBN	B-ADJP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
pelvic	pelvic	JJ	I-NP	O
and	and	CC	I-NP	O
abdominal	abdominal	JJ	I-NP	O
CT	CT	NN	I-NP	O
on	on	IN	B-PP	O
2/1/99	2/1/99	CD	B-NP	O
which	which	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
bilateral	bilateral	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
abscess	abscess	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
punctate	punctate	VB	B-VP	O
renal	renal	JJ	B-NP	O
stones	stone	NNS	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
uropathy	uropathy	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
fever	fever	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

First	First	RB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
maintained	maintain	VBD	B-VP	O
relatively	relatively	RB	B-NP	O
benign	benign	JJ	I-NP	O
urinalysis	urinalysis	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
collected	collect	VBN	I-VP	O
only	only	RB	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-SBAR	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
believe	believe	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
ever	ever	RB	I-VP	O
had	have	VBN	I-VP	O
pyelonephritis	pyelonephritis	NN	B-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
her	her	PRP	B-NP	O
persistently	persistently	RB	B-ADVP	O
elevated	elevate	VBD	B-VP	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
unclear	unclear	JJ	B-ADJP	O
although	although	IN	B-SBAR	O
it	it	PRP	B-NP	O
did	do	VBD	B-VP	O
finally	finally	RB	B-ADJP	O
decline	decline	JJ	I-ADJP	O
.	.	.	O	O

In	In	IN	B-PP	O
short	short	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
series	series	NN	I-NP	O
of	of	IN	B-PP	O
events	event	NNS	B-NP	O
that	that	WDT	B-NP	O
led	lead	VBD	B-VP	O
up	up	IN	B-PP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
appeared	appear	VBD	B-VP	O
likely	likely	JJ	B-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
tachycardia	tachycardia	NN	B-NP	O
and	and	CC	I-NP	O
demand	demand	NN	I-NP	O
related	related	JJ	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
combination	combination	NN	B-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
and	and	CC	O	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
leads	lead	VBZ	B-VP	O
to	to	TO	B-PP	O
nonhepatic	nonhepatic	JJ	B-NP	O
hyperosmolar	hyperosmolar	JJ	I-NP	O
state	state	NN	I-NP	O
.	.	.	O	O

Nonetheless	Nonetheless	RB	B-ADVP	O
,	,	,	O	O
a	a	DT	B-NP	O
different	different	JJ	I-NP	O
sequence	sequence	NN	I-NP	O
of	of	IN	B-PP	O
pathologies	pathology	NNS	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
possible	possible	JJ	B-ADJP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
hydrochlorothiazide	hydrochlorothiazide	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
NPH	NPH	NN	B-NP	B-protein
30	30	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-VP	O
q.	q.	VBG	I-VP	O
AM	AM	NN	B-NP	O
;	;	:	O	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-VP	O
q.	q.	VBG	I-VP	O
AM	AM	NN	B-NP	O
;	;	:	O	O
magnesium	magnesium	NN	B-NP	O
gluconate	gluconate	NN	I-NP	O
1	1	CD	I-NP	O
gram	gram	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Isordil	Isordil	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
;	;	:	O	O
metoprolol	metoprolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
;	;	:	O	O
simvastatin	simvastatin	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
losartan	losartan	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
Allegra	Allegra	NNP	B-NP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
;	;	:	O	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
1	1	CD	I-NP	O
tablet	tablet	NN	I-NP	O
q.	q.	NN	I-NP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
x3	x3	CD	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
PHIL	PHIL	NNP	B-NP	O
POMYKALA	POMYKALA	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
BT08	BT08	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GRANT	GRANT	NNP	B-NP	O
R.	R.	NNP	I-NP	O
AMADI	AMADI	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CV3	CV3	NNP	I-NP	O
KZ703/1893	KZ703/1893	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
44742	44742	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

QJQA2140T8	QJQA2140T8	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
3/19/99	3/19/99	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/9/99	10/9/99	CD	B-NP	O

